Passwort anzeigen
Passwort vergessen?
Werden Sie kostenlos Mitglied
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Dynamische Kurse 
  1. Startseite
  2. Aktien
  3. Deutschland
  4. Xetra
  5. Bayer AG
  6. News
  7. Andere Sprachen
    BAYN   DE000BAY0017   BAY001


ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über BAYER AG
22.09.BAYER : Vividion doté d'un conseil scientifique consultatif
22.09.PRESS RELEASE : Pfizer and BioNTech Expand -3-
22.09.BAYER : lancement de semences de légumes biologiques
22.09.ECONOMIA : il big pharma non paga l'Italia (MF)
22.09.BAYER : Plans 2022 Launch For Vegetable Products Portfolio
21.09.PRESS RELEASE : Tele Columbus AG: New product portfolio and offers for autumn: PYUR confir..
20.09.BÖRSE FRANKFURT : Le Dax trébuche pour sa première séance à 40 valeurs
20.09.BAYER : Launches Study To Evaluate Nondiabetic Chronic Kidney Disease Treatment
20.09.BAYER : lance une étude de phase III sur la finerénone
20.09.BAYER : extends clinical development program for finerenone with Phase III study in patien..
20.09.PRESS RELEASE : Tele Columbus AG: M7 and PYUR extend partnership
20.09.Bayer Extends Clinical Development Program for Kerendia
20.09.PRESS RELEASE : Pfizer and BioNTech Announce -3-
20.09.WYLD : Signs Deal With Bayer Unit For Satellite System For Beehives
20.09.PRESS RELEASE : AiCuris starts pilot trial with proprietary immunomodulator AIC649, a uniq..
20.09.BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
20.09.BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
20.09.Première séance pour le Dax 40 élargi et rajeuni
18.09.PRESS RELEASE : FDA Advisory Committee Votes -3-
16.09.BWXT Medical to Collaborate With Bayer on Actinium-225 Radioisotope Development
16.09.BAYER : lance un registre de transparence en Allemagne
16.09.BAYER : launches transparency register for scientific collaborations with external partner..
16.09.BAYER : l'efficacité du Vitrakvi confirmée par quatre études
16.09.BAYER : Reports 'Sustained Clinical Benefit' From New Studies on Vitrakvi Cancer Drug
16.09.BAYER : Latest analyses of Vitrakvi (larotrectinib) reaffirm powerful efficacy and tolerab..
15.09.PRESS RELEASE : Tele Columbus AG: Eisenbahner-Wohnungsbaugenossenschaft (EWG) and Tele Col..
15.09.Deutsche Bank Eyes External Candidates for Chairman
14.09.BAYER : 15 millions de dollars levés au bénéfice d'Andes
14.09.BAYER : Unit Co-Leads $15 Million Funding Round for US-Based Biotechnology Group
14.09.BAYER : Andes Raises USD 15 Million in Series A Funding Co-Led by Leaps by Bayer and Caval..
13.09.BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
09.09.BOLSA : Europa cierra dispar tras reunión de política monetaria del BCE
09.09.VC DAILY : Digital Health Is Booming, but VC Doesn't See a Bubble Forming
09.09.BAYER : To Release New Data On Cancer Treatments At ESMO Congress
09.09.BAYER : to highlight expanded research from growing oncology portfolio at ESMO Congress 20..
09.09.BOLSA : Europa cae antes de reunión de política monetaria del BCE
08.09.PRESS RELEASE : Tele Columbus AG: PYUR cable network in Flensburg to be upgraded
08.09.BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
08.09.BAYER AKTIENGESELLSCHAFT : Release according to Article 40, Section 1 of the WpHG [the Ger..
06.09.CAC40 vs DAX40
06.09.BAYER : résultats positifs dans la toux chronique réfractaire
06.09.BAYER : Investigational Drug Reduces Cough Frequency In Mid-Stage Trial
06.09.BAYER : Eliapixant significantly decreased cough frequency in Phase IIb trial in patients ..
03.09.PRESS RELEASE : Tele Columbus AG: Delisting of shares of Tele Columbus AG from Frankfurt S..
01.09.PRESS RELEASE : Tele Columbus AG: PYUR customer service earns top scores in 'connect' hotl..
31.08.Bayer Starts Phase III Clinical Development Program Oasis with Investigational Product,..
31.08.BAYER : lance une étude de phase III autour de l'elinzanetant
31.08.BAYER : Kicks Off Phase III Trial For Treatment Of Vasomotor Symptoms During Menopause
31.08.BAYER : starts Phase III clinical development program OASIS with Elinzanetant
30.08.BAYER : New Data on Finerenone for the protection of patients with chronic kidney disease ..
30.08.BAYER : résultats positifs pour la fineronone
30.08.BAYER : Finerenone Cuts Risk of Heart Problems, Death in Late-Stage Study
28.08.Bayer Aktiengesellschaft Announces Detailed Results from the Phase III FIGARO-DKD Study
28.08.BAYER : New Data on Finerenone for the protection of patients with chronic kidney disease ..
27.08.PRESS RELEASE : Joint Communiqué: BioNTech Evaluates mRNA Vaccine Manufacturing Solutions ..
26.08.PRESS RELEASE : Pfizer and BioNTech Announce -3-
26.08.BAYER : la durée d'application de Mirena prolongée aux USA
26.08.BAYER : Syngenta Group benefits from farmers restocking as Q2 sales rise 28%
26.08.PRESS RELEASE : Tele Columbus AG: Mixed operational performance in Q2, important transac-t..
25.08.DGAP-ADHOC : Tele Columbus AG: Clarification on revised guidance for fiscal year 2021
25.08.PRESS RELEASE : Pfizer and BioNTech Initiate -3-
25.08.DGAP-ADHOC : Tele Columbus AG: Guidance update for the financial year 2021 and beginning o..
25.08.CardieX Subsidiary ATCOR Announces New Clinical Trial Expansion with Bayer AG
24.08.BAYER : la FDA élargit l'indication du Xarelto
24.08.BAYER : U.S. FDA approves expansion of the peripheral artery disease (PAD) indication for ..
24.08.DGAP-PVR : Bayer Aktiengesellschaft: Release -2-
24.08.DGAP-PVR : Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpH..
23.08.PRESS RELEASE : Pfizer-BioNTech COVID-19 Vaccine -3-
19.08.VC HEALTH PULSE : General Catalyst, HCA Healthcare Team Up on Digital Innovation; Illumina..
19.08.BAYER : investit 45 M$ dans Sound Agriculture
19.08.PRESS RELEASE : Tele Columbus AG: Direct optical fibre connection plus open access model f..
19.08.BAYER : to present data from cardiovascular portfolio, including late breaking data from P..
1  2  3  4  5  6  7  8  9  10Weiter